Ezra Aurien-Blajeni

Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.

Mark E. Williams, P. Kimmel, A. Hung, 2019, Kidney international.